Our study primarily demonstrated the ability of LINC00472 to competitively bind to miR‐23a‐3p to boost the FOXO3 expression and transcriptionally activate the BID expression for suppression of pancreatic cancer progression. Here, FOXO3 is linked to pancreatic neoplasm.